UK’s NHS Facing Major Leadership Shake-Up
After several scandals that revealed longstanding deficiencies and a continual churn of executive staff, a recent independent review of leadership in the National Health Service (NHS) has uncovered a lack…
Address: 13 Windsor Street, Islington, London N1 8QG,United Kingdom
Tel: +44(0)20 7288 7008
An elegant corporate events venue for business meetings & private conferences in Islington, London.
Many clients comment on how well their functions turn out at The Window. The combination of the light, spacious ambience and the friendly, responsive events team, allows clients to step out of the ordinary “conference mode” and encourages creative thinking and open dialogue.
Whether it’s for a business conference, a product launch, training seminar or executive meeting, the flexible floor spaces add that extra imaginative flair and the personalised client service takes care of the details to ensure an event is a complete success.
Venu hire for corporate events or private events.
The Window offers four distinctive and complementary floor spaces with eight rooms to suit varying needs. The elegant entrance way, flanked by a rock garden and over-hanging balcony, welcomes clients into a light and spacious two tiered reception floor.
The top floor conference room provides the focal point for the event. Its panoramic view of the London skyline and trade mark 12ft window make this an impressive backdrop for corporate presentations. Third floor executive suite and meeting rooms are ideal for smaller meetings and presentations. Audio Visual Services are also available on request.
The dining area, supported by specialist in-house catering services, can also be used as a secondary conference floor. Its more informal and relaxed environment lends itself to break out groups, private meetings and informal gatherings. Additional private rooms are also available upon request.
The Window’s prime location is supported by good transport links with Angel and Highbury & Islington underground stations and an NCP car park, all within a 10 minute walk. Wheelchair access is provided to all floors and The Hilton Hotel is close by for delegates requiring overnight accommodation.
After several scandals that revealed longstanding deficiencies and a continual churn of executive staff, a recent independent review of leadership in the National Health Service (NHS) has uncovered a lack…
Just one year after the UK government published its Life Science Vision, outlining the ambitions of the government and the life science sector for the next 10 years, the Association…
After a tumultuous year, AstraZeneca is creating a standalone vaccine unit and will begin to charge for its COVID-19 vaccine shot, having previously provided it at cost. PharmaBoardroom looks back…
The latest news from UK pharma, including AstraZeneca’s decision to create a dedicated business unit for its COVID-19 vaccines, GSK’s raised profits forecast, and CDMO Almac’s move to create over…
Cyril Titeux, senior VP mid-sized markets EMEA & strategic leader at Janssen, argues that the current focus of many health systems on efficiency, streamlining, and reducing spending is leaving them…
British pharmaceuticals giant, GSK, one of the UK’s largest companies by market capitalization, is once again finding itself under the spotlight as analysts and shareholders alike continue to query the…
Kathy Pritchard-Jones, Professor of Paediatric Oncology at University College London (UCL) and President of the International Society of Paediatric Oncology (SIOP) discusses the latest advancements in childhood cancer treatment, the…
Zack Pemberton-Whiteley, CEO of UK-based blood cancer charity Leukaemia Care, discusses the importance of patient and patient organizations’ involvement in the decision-making process for therapy appraisals, the use of HTA,…
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and litigation examines the origins and fallout of the EU/AstraZeneca vaccine dispute and why the twin forces of…
The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma giant; CDMO Sterling’s latest acquisition; and calls for a national registry to…
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical company successfully listed on NASDAQ, raising over USD 30 million. Founded…
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to leave the European Union, some analysts feared that Britain could become left…
See our Cookie Privacy Policy Here
